Loading…
Shree Ganesh Remedies (SGRL)₹608.65−3.26%Pharmaceuticals
Shree Ganesh Remedies is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 50.4 against a peer median of 37.7, and ROCE of 14.0% against a peer median of 13.9%, and latest-quarter sales growth of −41.8% against a peer median of 4.3%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharmaceuticals | 968 | 26.2 | 17.1 | 12.3 | 0.08 | 0.1 | 853 | 46 | 30.2 | 19.1 | vs SGRL |
| Themis Medicare | 939 | 23.5 | 3.0 | 0.4 | 0.25 | 0.5 | 342 | 1 | −11.1 | — | vs SGRL |
| Shree Ganesh Remedies | 861 | 71.6 | 13.9 | 10.8 | 0.16 | 0.0 | 109 | 18 | −23.2 | −67.0 | vs SGRL |
| Anuh Pharma | 828 | 18.6 | 15.1 | 10.7 | 0.00 | 1.8 | 776 | 41 | 4.3 | 37.6 | vs SGRL |
| Aptus Pharma | 811 | 175.8 | 30.0 | 30.5 | 0.31 | 0.0 | 46 | 5 | 117.3 | 60.0 | vs SGRL |
| Amanta Healthcare | 784 | 54.2 | 12.0 | 10.4 | 1.12 | 0.0 | 289 | 15 | 5.3 | −5.7 | vs SGRL |
| Shree Ganesh Remedies | 779 | 50.4 | 14.0 | 10.9 | 0.19 | 0.0 | 109 | 18 | −41.8 | −67.3 | — |
| Zim Laboratories | 735 | 180.1 | 5.0 | 1.6 | 0.43 | 0.0 | 374 | 6 | 31.4 | — | vs SGRL |
| Kilitch Drugs (India) | 701 | 23.2 | 13.1 | 10.5 | 0.32 | 0.0 | 235 | 30 | 4.0 | −13.6 | vs SGRL |
| Wanbury | 700 | 10.4 | 31.1 | 68.4 | 1.56 | 0.0 | 648 | 66 | −4.1 | 10.0 | vs SGRL |
| Valiant Laboratories | 605 | 37.7 | 1.0 | −1.2 | 0.15 | 0.0 | 237 | −3 | 145.0 | 945.3 | vs SGRL |
| Peer median | 784 | 37.7 | 13.9 | 10.7 | 0.25 | 0.0 | 289 | 18 | 4.3 | 10.0 |
Listed companies closest to Shree Ganesh Remedies in Pharmaceuticals include Remus Pharmaceuticals, Themis Medicare, Shree Ganesh Remedies, Anuh Pharma, Aptus Pharma, Amanta Healthcare, Zim Laboratories, Kilitch Drugs (India).
Remus Pharmaceuticals, with a market cap of ₹968 Cr.
Shree Ganesh Remedies trades at a P/E of 50.4; the median of its peer set is 37.7. A P/E above or below the median is a description, not a judgement on value.
Shree Ganesh Remedies' return on capital employed is 14.0%, above the peer median of 13.9%.